U.S. federal trademark · Serial No. 98004249
Research and development in the field of oligonucleotide drug delivery platforms for use in the treatment of genetic diseases and disorders; research and development in the field of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of genetic diseases and disorders; and research and development in the field of oligonucleotide compounds for targeted gene silencing.
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.